MOLN
Price
$3.68
Change
+$0.01 (+0.27%)
Updated
Sep 24, 04:29 PM (EDT)
Capitalization
135.23M
36 days until earnings call
SNSE
Price
$9.20
Change
+$0.07 (+0.77%)
Updated
Sep 24, 03:33 PM (EDT)
Capitalization
11.52M
Interact to see
Advertisement

MOLN vs SNSE

Header iconMOLN vs SNSE Comparison
Open Charts MOLN vs SNSEBanner chart's image
Molecular Partners AG
Price$3.68
Change+$0.01 (+0.27%)
Volume$700
Capitalization135.23M
Sensei Biotherapeutics
Price$9.20
Change+$0.07 (+0.77%)
Volume$100
Capitalization11.52M
MOLN vs SNSE Comparison Chart in %
Loading...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MOLN vs. SNSE commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOLN is a Hold and SNSE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (MOLN: $3.67 vs. SNSE: $9.13)
Brand notoriety: MOLN and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MOLN: 310% vs. SNSE: 29%
Market capitalization -- MOLN: $135.23M vs. SNSE: $11.52M
MOLN [@Biotechnology] is valued at $135.23M. SNSE’s [@Biotechnology] market capitalization is $11.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MOLN’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • MOLN’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, both MOLN and SNSE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MOLN’s TA Score shows that 4 TA indicator(s) are bullish while SNSE’s TA Score has 5 bullish TA indicator(s).

  • MOLN’s TA Score: 4 bullish, 6 bearish.
  • SNSE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than MOLN.

Price Growth

MOLN (@Biotechnology) experienced а +0.82% price change this week, while SNSE (@Biotechnology) price change was +2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

MOLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($135M) has a higher market cap than SNSE($11.5M). SNSE YTD gains are higher at: -6.856 vs. MOLN (-22.704). SNSE has higher annual earnings (EBITDA): -26.03M vs. MOLN (-62.52M). MOLN has more cash in the bank: 114M vs. SNSE (28.6M). MOLN has less debt than SNSE: MOLN (1.84M) vs SNSE (2.56M). MOLN has higher revenues than SNSE: MOLN (681K) vs SNSE (0).
MOLNSNSEMOLN / SNSE
Capitalization135M11.5M1,174%
EBITDA-62.52M-26.03M240%
Gain YTD-22.704-6.856331%
P/E RatioN/AN/A-
Revenue681K0-
Total Cash114M28.6M399%
Total Debt1.84M2.56M72%
TECHNICAL ANALYSIS
Technical Analysis
MOLNSNSE
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
68%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCBC36.38-0.08
-0.22%
First Community Bankshares
NMR7.47-0.02
-0.27%
Nomura Holdings
SPAI7.11-0.03
-0.42%
Safe Pro Group Inc
KAR28.26-0.63
-2.18%
OPENLANE
FEMY0.34-0.02
-4.70%
Femasys

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
N/A
SNSE - MOLN
42%
Loosely correlated
+2.01%
ATRA - MOLN
34%
Loosely correlated
+5.45%
HURA - MOLN
30%
Poorly correlated
-1.96%
GUTS - MOLN
29%
Poorly correlated
+0.23%
GRI - MOLN
27%
Poorly correlated
-2.50%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with HURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+2.01%
HURA - SNSE
48%
Loosely correlated
-1.96%
VSTM - SNSE
46%
Loosely correlated
+0.66%
MOLN - SNSE
42%
Loosely correlated
N/A
GRI - SNSE
38%
Loosely correlated
-2.50%
INAB - SNSE
37%
Loosely correlated
-2.84%
More